Francois Guillemot

Neural Stem Cell Biology Laboratory

We study how the different types of cells that constitute the nervous system are generated at appropriate times and locations to form functional neural circuits.

We address these questions using the embryonic and adult mouse brain and human ESC/iPSC-derived cortical cultures and human foetal brain explant cultures as our experimental models. Our aim is to identify fundamental mechanisms that underlie the generation and functioning of the nervous system, and to contribute to the development of therapies to treat neurological disorders.

The main cellular components of the nervous system, neurons and glial cells, are generated by common progenitors or stem cells, located in specialised cell layers found throughout the embryonic brain and in restricted locations in the adult brain. The choice of stem cells to divide, remain quiescent or differentiate into neurons or glial cells, is dictated by extracellular signals including morphogens such as Wnts or BMPs, and, in the adult brain, by neurotransmitters that provide feedback signals from surrounding neuronal networks. We are interested in how stem cells integrate these multiple signals to select appropriate behaviours.

Although each brain region contains many different types of neurons and glial cells connected in highly specialised circuits, each stem cell usually produces only one type of neuron or glia at a particular time and place. We identify transcription factors that allow stem cells to select a particular fate, and study the mechanisms that control the precise timing of their expression and activity, including epigenetic mechanisms that regulate the accessibility of regulatory elements to transcription factors.

The transcription factors that specify stem cell fates often also induce the differentiated phenotype of the neuronal progenies. We investigate the mechanisms that control the switch of activity and change of downstream targets of transcription factors between progenitors and differentiating neurons. We also study the gene expression programmes induced by transcription factors in differentiating neurons, and the mechanisms responsible for the sequential expression of their targets and the progressive acquisition of the neuronal phenotype.

As neurons differentiate, they leave the stem cell layers where they were born and migrate to locations where they wire with other neurons and establish circuits. Neuronal migration requires the precise regulation of a large number of genes involved in cytoskeleton remodelling as well as the monitoring of environmental cues that allow neurons to follow defined routes. We study the gene regulatory programme controlling neuronal migration and its modulation by extrinsic signals that direct the migration of neurons.

Brain development is disrupted in humans afflicted by various neurodevelopmental disorders such as autism, epilepsy and intellectual disabilities. We study the normal and pathological functions of transcriptional regulators and chromatin remodeling factors that have been found to be mutated in neurodevelopmental disorders. We use human ESC- and iPSC-derived neuronal cultures and foetal brain explant cultures to identify the cellular and molecular mechanisms underlying the normal developmental functions of these disease-associated factors, and to determine how these mechanisms are affected and brain development is disrupted when these factors carry pathological mutations. 

Stem cells in the hippocampus of an adult mouse

Stem cells in the hippocampus of an adult mouse labelled by neural stem cells markers.

Selected publications

Urban, N., van den Berg, D.L.C., Forget, A., Andersen, J., Demmers, J.A., Hunt, C., Ayrault, O., Guillemot, F. (2016). Return to quiescence of mouse neural stem cells by degradation of a pro-activation protein. Science 353, 292-295.

Garcez, P.P., Diaz-Alonso, J., Crespo-Enriquez, I., Castro, D., Bell, D., Guillemot, F. (2015) Cenpj/CPAP regulates progenitor divisions and neuronal mi.gration in the cerebral cortex downstream of Ascl1Nat. Commun. In press.

Andersen, J., Urbán, N., Achimastou, A., Ito, A., Simic, M., Ullom, K., Martynoga, B., Lebel, M., Göritz, C., Frisén, J., Nakafuku, M., Guillemot F. (2014) A transcriptional mechanism integrating inputs from extracellular signals to activate hippocampal stem cellsNeuron, 83, 1085-1097.

Martynoga, B., Mateo, J.L., Zhou, B., Andersen, J., Achimastou, A., Urbán, N., van den Berg, D., Georgopoulou, D. , Hadjur, S., Wittbrodt, J., Ettwiller,L., Piper, L., Gronostajski, R.M., Guillemot, F. (2013). Epigenomic enhancer annotation reveals a key role for NFIX in neural stem cell quiescenceGenes Dev. 27, 1769-1786.

Francois Guillemot
+44 (0)20 379 61458

  • Qualifications and history
  • 1989 PhD Institut d'Embryologie du CNRS, Paris, France
  • 1989-1991 Postdoctoral fellow Harvard Medical School, Boston, USA
  • 1991-1994 Postdoctoral fellow Mount Sinai Hospital, Toronto, Canada
  • 1994 Group Leader, IGBMC, Strasbourg, France
  • 2002 Group Leader, Medical Research Council National Institute for Medical Research, London, UK
  • 2015 Group Leader, the Francis Crick Institute, London, UK